Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Biotech
Beeline bolsters autoimmune ambitions with $126M
The funds come from existing backers Bain Capital, the Canada Pension Plan Investment Board and BMS, which also provided the biotech's five programs.
Darren Incorvaia
Jun 30, 2026 7:00am
BIO 2026: How a gut feeling transformed cancer treatment forever
Jun 25, 2026 9:23am
Takeda’s TYK2 inhibitor beats BMS’ Sotyktu in psoriasis showdown
Jun 11, 2026 7:00am
Fierce Pharma
At ASCO, China biotech industry cements its coming of age
Jun 3, 2026 8:50am
ASCO: BMS' bispecific ADC puts TROP2 drugs on notice
Jun 2, 2026 8:00am
ASCO: BioNTech/BMS, Pfizer split on bispecific approach in NSCLC
May 30, 2026 3:30pm
